Medicine

News

10 Jun 2026
Kanazawa University
Physician-scientists at Kanazawa University have demonstrated, for the first time worldwide, the clinical efficacy of chemoimmunotherapy in patients with ultra-rare urachal cancer. Furthermore, their reverse translational research elucidated the mechanism by which the addition of immunotherapy enhances the efficacy of chemotherapy.
older adult injured bone
09 Jun 2026
Osaka Metropolitan University
Pinpointing associated factors that contribute to injury in older adults
05 Jun 2026
Kanazawa University
Patients with stroke undergoing inpatient rehabilitation differ in how sedentary time accumulates and changes over one month.
“Research, at its best, is an act of service,” said Ateneo de Manila University Assistant Vice President for Research, Creative Work, and Innovation Dr. FIlomeno Aguilar Jr at the Second Philippine Human-Animal Bond Conference, as Communitails co-founder Dr. Camille Asuncion looks on. With them, front and center, are standees representing just some of Communitails’ many beloved therapy dogs—“therapy dogtors” in their own right. PHOTO: Ateneo de Manila University.
04 Jun 2026
Ateneo de Manila University
PHABCON 2026, advanced research on human-animal bonds as pathways to healing, care, and connection.
02 Jun 2026
The University of Osaka
Researchers at The University of Osaka used a focused laser beam to make in vitro models of cytoskeletal networks that exhibit dynamic cell-like motions. This technique provides spatiotemporal control of the network structure, unlike conventional methods based on self-organization and photochemical reactions. The models could be used to determine the structure–motion relationship of cytoskeletal networks, which has applications for understanding cell division, migration, and adhesion and the creation of protein-based robots and synthetic cells.
02 Jun 2026
The University of Osaka
Researchers from The University of Osaka found that nanomicelle-mediated delivery of five mRNAs involved in angiogenesis, heart cell contraction, immune and hematopoietic stem cell recruitment, and immune response suppression promoted cardiac repair and increased overall survival in a mouse model of myocardial infarction–induced heart failure. These findings suggest that a multifactorial treatment approach effectively addresses the complex nature of heart failure and could aid new treatments in regenerative medicine for cardiovascular disease.
A tired woman laying under poor diet
28 May 2026
Osaka Metropolitan University
Diet and homocysteine may influence fatigue and motivation
27 May 2026
National Taiwan University
By regulating EGFR trafficking to late endosomes and attenuating AKT and ERK signaling, CASK suppresses p21 expression and promotes proliferation in NSCLC cells.
26 May 2026
National Taiwan University
National Taiwan University Hospital (NTUH), in collaboration with multiple medical centers across Taiwan, has found that patients with hepatitis C remain at a significantly elevated risk of hepatocellular carcinoma (HCC) even after successful viral eradication with direct-acting antivirals (DAAs), particularly if metabolic dysfunction–associated steatotic liver disease (MASLD) is present.
 Position of Mutation Determines HI or DN Effects in RELA Nonsense Variants
22 May 2026
Hiroshima University
Position of a RELA mutation can shape symptoms, severity and treatment response
21 May 2026
The University of Osaka
Researchers from The University of Osaka found that only a small subset of tumor-killing T cells undergoes extensive expansion during immunotherapy for multiple myeloma. By tracking individual cells, the team showed that the T-cell clones that later became dominant had already begun expanding shortly after the treatment started. The findings also suggest that highly proliferative immune cells show lower levels of exhaustion-related markers, offering new insights into why some patients respond better to immunotherapy.
20 May 2026
National Institute for Materials Science (NIMS)
Engineered carbon-based nanomaterials can interfere with the aggregation of misfolded proteins linked to neurodegenerative diseases, offering a new direction for future therapeutic exploration.
18 May 2026
Professor Liang Wang has just been appointed new Lead Editor in Microbiology in Health and Disease at the Journal of Applied Microbiology. In a fascinating new Q&A, he discusses antimicrobial resistance, emerging fields in microbiology and Helicobacter pylori.
18 May 2026
Tohoku University
Millions of people across the world suffer from Alzheimer’s disease, where sufferers experience memory impairment. Researchers from Tohoku University and the University of California, Irvine have recently identified dopamine dysfunction as a previously unrecognized mechanism underlying memory impairment. The discovery potentially opens the door to new therapeutic means that could reverse cognitive decline in Alzheimer’s patients across the globe.
18 May 2026
Osaka Metropolitan University
Researchers have developed an optical fiber that uses laser-induced heating and bubble-driven convection to rapidly concentrate bacteria and nanoparticles in liquid samples. The method collects thousands of targets in 60 seconds with over tenfold higher efficiency than conventional approaches. This approach allows for faster and more sensitive detection in biomedical and environmental applications.
17 May 2026
Duke-NUS Medical School
More than a student event or hospital outreach effort, Paediatric Brain and Solid Tumour Awareness (PBSTA) Day has become a growing community of support for children living with cancer and the families who care for them.
15 May 2026
Osaka Metropolitan University
Researchers found that FK 23, a lactic acid bacterium-derived material, improved the sperm dysfunction induced by bisphenol A (BPA)—a chemical commonly used in plastic production including food containers—using a rat model.
15 May 2026
The prize, in partnership with Nature, will celebrate breakthroughs in mental health science. It aims to accelerate translation, influence policy and transform lives. This award champions new pharmacological, psychological, social and digital interventions from around the world. The overall winner will receive USD 1 million, and three finalists will be awarded USD 250,000 each.
14 May 2026
Ehime University
We revealed that the proton channel Hv1/VSOP, previously thought to function at the cell surface in microglia (brain immune cells), also functions on endosomes inside cells and precisely controls the actin cytoskeleton. Using advanced microscopy and electrophysiology (endosome patch-clamp), we found Hv1 acts as a brake on actin elongation. This discovery presents a novel cellular control mechanism where endosomal ion channels manipulate the cell skeleton itself, with implications for understanding neurodegenerative diseases.
14 May 2026
Osaka Metropolitan University
A high-resolution cellular atlas of liver fibrosis and recovery identifies two proteins, SEMA4D and LMCD1, as promising therapeutic targets. The findings were validated in both mouse models and human patient samples, suggesting relevance to human disease.
14 May 2026
Springer Nature
Obesity trends have continued to rise in low- and middle-income countries over the past 45 years, but have plateaued in many high-income countries, a study in Nature reports.
13 May 2026
More than a decade after the Nagoya Protocol, which aims to fairly share the benefits of utilizing genetic resources, became law, microbiologists and other scientists still face practical challenges and confusion. A new guide published by a team of microbiologists provides universally applicable frameworks for anyone working with biological resources.
Loss of X Chromosome image
12 May 2026
Osaka Metropolitan University
Cellular changes affect ability to conceive
12 May 2026
The University of Osaka
Researchers from The University of Osaka found that the zinc finger proteins RLF and ZFP292 play redundant roles in stabilizing the CoREST corepressor complex at gene promoters in embryonic stem cells. Deleting both proteins allowed the cells to differentiate, suggesting that they could be useful targets for maintaining stem cell quality.
Hemorrhagic pneumonia
11 May 2026
Osaka Metropolitan University
Drug resistance of Stenotrophomonas maltophilia prompts need for effective alternative treatments
08 May 2026
Tohoku University
Stubborn cancer tumors were completely (and safely) eliminated in a mouse model with a small but mighty treatment method using nanoparticles, controlled drug release in stages, and light from lasers.
08 May 2026
National Taiwan University
Researchers at National Taiwan University have developed a liver-directed IL-10 gene therapy that strengthens cancer-fighting immune cells and suppresses liver tumors in mice. The treatment also generated long-lasting immune memory cells that remained in the liver after tumors disappeared.
07 May 2026
Hiroshima University
A large-scale study of more than 31,000 patients found pneumonia occurred more often after breathing tubes were removed than during ventilation. Researchers say the condition, tied to swallowing dysfunction, should be recognized as a distinct clinical entity—one that may be preventable with early intervention.
23 Apr 2026
Tohoku University
Researchers at Tohoku University have discovered hidden genetic damage that has been overlooked for decades, which could lead to more accurate research on aging and diseases like cancer. This groundbreaking discovery opens the door to more reliable technologies for working with DNA in the future.

Events

07 Oct 2021
The National Healthcare Group (NHG) is proud to present the 19th Edition of the Singapore Health & Biomedical Congress (SHBC).
24 Feb 2021
INTERPHEX Week Osaka is Asia's leading exhibition for pharmaceutical industry, consists of 2 exhibitions for pharmaceutical technologies - INTERPHEX OSAKA (Manufacturing & Packaging) and PharmaLab Expo OSAKA (Pharma R&D and Drug Discovery).
23 Nov 2020
Global health emergencies look set to be a part of our lives. What awaits us in 2021 and what lessons can we draw from COVID-19 coverage? How can we support newsrooms and journalists for more informed and impactful journalism about global scientific, technical and human challenges? What role does journalism play in seeking solutions for a better world that is both healthy, and sustainable?
27 Nov 2020
ACRLS 2020 aims to contribute to strengthening cooperation and relationship among members worldwide and forming a strong global network by providing various benefits to robotic clinics in rapidly growing nations throughout Asia.
25 Nov 2020
Asia's Leading Pharma & Bio Tech Show will be held as scheduled from November 25-27, 2020 at Makuhari Messe, Japan. It will be held both on-site and online.
16 Nov 2020
Optimising Clinical Trials | Commercialising Great Science | Partnering for Growth
02 Nov 2020
We invite scientists, doctors, students and other delegates engaging in scientific research related to cancer to join us at Singapore’s preferred cancer conference.
The Khwarizmi International Award (KIA) acknowledges the efforts made by researchers, innovators and inventors from across the globe and to appreciate their high quality research work and contributions to different fields of science and technology.
01 Oct 2020
The 6th annual RNA Biology Symposium jointly organized by the RNA Biology Centre of CSI Singapore (NUS), Skin Research Institute of Singapore (A*STAR), Duke-NUS Medical School, School of Biological Sciences (NTU) and Singapore-MIT Alliance for Research and Technology (SMART)
26 Jun 2020
Flattening the Curve with Digital Health: Episode 7 - Australia
18 Jun 2020
Flattening the Curve with Digital Health: Episode 6 - Thailand
10 Jun 2020
Flattening the Curve with Digital Health: Episode 5 - Japan
04 Jun 2020
Flattening the Curve with Digital Health; Episode 4 - Malaysia
28 May 2020
Flattening the Curve with Digital Health: Episode 3 - South Korea
23 Sep 2020
Adapting to COVID 19, and driving a pivotal change in drug trials, market penetration, pricing and regulatory compliance
02 Sep 2020
Celebrating and learning from COVID 19 success stories to shape new frontiers in patient experience, healthtech and innovation.
14 May 2020
Flattening the Curve with Digital Health - Episode 1 - China
21 May 2020
Flattening the Curve with Digial Health - Episode 2: Singapore
14 Oct 2020
Asia's Premier Partnering Event for the Global Biotechnology Industry. This year’s exhibition will be held as originally planned at Pacifico Yokohama. BioJapan partnering is available both physically and virtually. Plus some seminars will be available online.
22 Jul 2020
Due to the COVID-19 pandemic affecting international travel, this year's event will be a unique blend of online and live gatherings — BIO Asia–Taiwan 2020 Online + Live, to be held July 22-26 in Taipei, Taiwan.
03 Nov 2020
Your go-to event to reach out to key decision makers in the pharmaceutical industry. The event will be delivered digitally from 3-5 November 2020.
09 Dec 2019
The ASEAN Emerging Researchers Conference is a flagship programme of the ASEAN Young Scientists Network; the official platform for young researchers in the region.
08 Dec 2020
Asia's pharma & biotech virtual festival - Phar-East is the premier meeting place for senior executives from Asia’s pharma and biotech industry.
26 Feb 2020
Japan's Leading Exhibition for Pharmaceutical R&D and Manufacturing Technologies!
26 Nov 2019
Vaccine World Asia 2019 will bring together leading experts to discuss the latest technological advancements and spearhead scientific innovation in the development and manufacture of vaccines for key diseases such as Dengue, Chikungunya, Malaria, Tuberculosis etc.
07 Nov 2019
Fostering Young Intellectuals for a Better Future
03 Oct 2019
Deadline for online registration 20 September 2019! We are excited to host our 5th annual RNA Biology Symposium by the RNA Biology Centre of CSI Singapore, NUS. It will be held at the Clinical Research Centre (MD11) Auditorium, 10 Medical Drive, Singapore 117597.
20 Nov 2019
Organising partner - the Australian Digital Health Agency
07 Oct 2019
Tracks include: Sustainability & Growth; Patient Experience; Unlocking the Value of AI; Value-based Care.

Researchers

Dr. Pablo Bifani
The Agency for Science, Technology and Research (A*STAR)
Dr. Bifani is a principal investigator at A*STAR ID Labs at their Antimicrobial Resistance Lab. He has extensively researched antimicrobial resistance in tuberculosis and malaria. He is also an associate professor and research director at the Yong Yoo Lin School of Medicine, National University of Singapore.
Jian Yan
City University of Hong Kong (CityUHK)
Dr. Yan is an assistant professor at the Department of Biomedical Sciences, City University of Hong Kong (CityU). His current research focuses on developing genomic tools to dissect lncRNA function and mechanism in diseases and to identify genetic variations that contribute to disease pathogenesis.
Xin Deng
City University of Hong Kong (CityUHK)
Dr. Deng is a biomedical scientist with a special interest in bacterial virulence, including gene regulation, signaling pathways, and RNA epigenetics. He has worked on virulence regulation in pathogens to discover new therapies against bacterial infections.
Toshiyuki Ozawa
Osaka Metropolitan University
Dr. Ozawa is a Specially Appointed Professor at the Department of Dermatology, Graduate School of Medicine, Osaka Metropolitan University (formerly Osaka City University). His specialized field is skin malignant tumor and surgery.
So Iwata
Kyoto University
Dr. So Iwata is a Professor at the Graduate School of Medicine Kyoto University and the Group Director of the SACLA Science Research Group, RIKEN SPring-8 Center. He has investigated how specialized membrane channels remove antimicrobial drugs from inside bacterial cells.
Robert Mitchell of UNIST
Ulsan National Institute of Science and Technology (UNIST)
Dr. Mitchell is a professor at the Department of Biological Sciences, Ulsan National Institute of Science and Technology (UNIST). His primary research interest is the study of bacterial strains that attack and prey on other bacteria, including antimicrobial-resistant pathogens.
Dr. Soojin Jang
Dr. Soojin Jang heads the Antibacterial Resistance Research Laboratory at Institut Pasteur Korea, where her team focuses on discovering new antibacterial agents for “superbugs” or bacteria resistant to most antibiotics.
Dr. Phan Thi Van
Dr. Van was previously the Director of the Research Institute for Aquaculture No.1 (RIA1) under Vietnam’s Ministry of Agriculture and Rural Development. She has extensive expertise in aquatic animal health and aquaculture safety management.
Dr Singh is working as an Additional Professor of Radiology. Besides specializing in medical Imaging, he has received certifications in Global Health, Science Diplomacy and Biomedical Research. His areas of interest and expertise are as follows: Radiology, Nuclear Medicine, Medicine, Health, Public Health, Global Health, Health Policy, Health Systems, evidence-based healthcare and Healthcare leadership.
Duke-NUS Medical School
Dr Kwa is currently a Pharmacy Clinician Scientist and Assistant Director, Pharmacy (Research), at the Singapore General Hospital. She specializes in critical care medicine, infectious diseases and antimicrobial resistance research.
 Liu Nan
Duke-NUS Medical School
Dr Liu Nan is an Associate Professor at Centre for Quantitative Medicine and Programme in Health Services and Systems Research, Duke-NUS Medicine School. His research focuses on health services research, emergency and prehospital care, cardiology, medical informatics, and health innovation
Universiti Teknologi MARA (UiTM)
Department of Microbiology / Biomolecular Sciences Universiti Teknologi MARA Malaysia
Suraj Bhattarai
Suraj Bhattarai is a global health specialist and tropical medicine physician with research interests in infectious disease epidemiology and surveillance, health systems, and urban health. He is a co-founder and research fellow at the Global Institute for Interdisciplinary Studies, a Kathmandu-based academic institute that promotes and conducts interdisciplinary research. He is a member of Global Young Academy and an Alumni steering committee member of IAP-Young Physician Leaders Programme. He obtained medical training in Nepal and masters in Tropical Medicine & International Health from the LSHTM, UK.
Takami Tomiyama
Osaka City University
Takami Tomiyama is currently an Associate Professor at the Graduate School of Medicine of Osaka City University.
International Islamic University Malaysia (IIUM)
Dr. Salizar Binti Mohamed Ludin is an Assoc. Prof at the Kulliyyah of Nursing of International Islamic University Malaysia.
Dr. Akira Kaneko
Osaka City University
Akira Kaneko was appointed as Professor of Parasitology of Osaka City University in 2010. Since then, he has conducted global health research with a particular focus on malaria elimination on islands in Vanuatu, Oceania and Lake Victoria, Kenya.
Jung Ah Cho
Daegu Gyeongbuk Institute of Science and Technology (DGIST)
Jung Ah Cho is a Visiting Professor at the School of Undergraduate Studies, College of Transdisciplinary Studies, DGIST.
Prof. Hiromitsu Toyoda
Osaka City University
Hiromitsu Toyoda is an associate professor at the Graduate School of Medicine of Osaka City University.
Kazuhisa Asai
Osaka City University
Kazuhisa Asai is currently an associate professor at the Graduate School of Medicine of Osaka City University.
Osaka City University
Tomoya Kawaguchi is a professor at Osaka City University. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer, EGFR Positive Lung Cancer, and Chronic Obstructive Pulmonary Disease.
Picture of Dr. Anna Kam Chi-shan
The Education University of Hong Kong (EdUHK)
Dr.Anna Kam's research interests include advanced technologies in aural rehabilitation, automated hearing screening, tinnitus management and auditory processing.
The Education University of Hong Kong (EdUHK)
Dr. Yuen has dual professional qualifications as an audiologist and a speech-language pathologist (or speech therapist). He is also an experienced cochlear implant clinical specialist audiologist.
Picture of Ann-Marie Chacko
Duke-NUS Medical School
Prof. Ann Marie Chacko lead the translational efforts for a portfolio of in vivo PET, SPECT, CT and optical imaging agents that span key therapeutic areas including oncology, immunology, infectious disease and neurobiology.
Duke-NUS Medical School
Prof. Patrick Tan's research focuses on developing genomic approaches to unlock the molecular and clinical diversity of gastric cancer (aka stomach cancer)- a leading cause of global cancer mortality.
Picture of Prof.Sohee Kim
Daegu Gyeongbuk Institute of Science and Technology (DGIST)
Prof.Sohee Kim's research focuses are the development of 2D and 3D flexible neural interfaces including brain interfaces, peripheral nerve interfaces, retina interfaces; polymer-based microfabrication technologies for soft bio-MEMS (micro-electro-mechanical system); and electrophysiology tools for zebrafish
Picture of Prof. David Bruce Matchar
Duke-NUS Medical School
Prof Matchar's research relates to clinical practice improvement - from the development of clinical policies to their implementation in real world clinical settings
Prof. Ooi Eng Eong
Duke-NUS Medical School
Professor Ooi Eng Eong is a clinician-scientist by training and his research on dengue is positioned at the interface between clinical epidemiology, virology and immunology. His laboratory is interested in how antibodies either protect against or enhance dengue virus infection and what viral factors influence epidemic dengue activity.
Hiroshima University
Prof. Kiyomi Shitaoka's research aims to obtain effective antibody genes and T cell receptor genes by single-cell analysis of B cell and T cell receptors on lymphocytes. In addition, to apply these genes to develop new treatments for overcoming infectious diseases and cancer.
Hiroshima University
Yohei Kawano is currently and Associate Professor at the Department of Immunology, Graduate School of Biomedical and Health Sciences, Hiroshima University.
Picture of Dr. Ren Kangning
Hong Kong Baptist University (HKBU)
Dr. Ken is currently an assistant professor in the department of Chemistry at HKBU. His current research interests center on advanced analytical chemistry technologies, with particular emphasis on creating and applying novel instrumental analysis technologies based on microfluidics and materials engineering.

Giants in history

Henriette Bui Quang Chieu (1906 – 2012) was inspired to follow in her brother’s footsteps and become a doctor after losing her mother to tuberculosis. She studied in France and became the first Vietnamese woman to receive a medical degree. Upon her return to Vietnam, Bui was appointed head of the Department of Midwifery at Cho Lon Hospital in Ho Chi Minh City. A pioneer in gynaecology, she applied acupuncture techniques that she had learned in Japan to obstetrics. As Vietnam was still a French colony, Bui also lobbied for the rights of Vietnamese doctors, nurses, and patients.
Japanese biochemist Akira Endo (1933 – 2024) discovered the first statin, called mevastatin, which lowered cholesterol levels in the blood by inhibiting a key enzyme in the cholesterol biosynthesis pathway. His work laid the foundation for the development of statins to help patients lower their blood cholesterol levels and reduce their risk of heart disease or stroke.
Tu Youyou (born 30 December 1930) is a Chinese pharmaceutical scientist who was awarded the 2015 Nobel Prize in Physiology or Medicine for her work on extracting artemisin from sweet wormwood to treat malaria.
Filipina paediatrician and scientist Perla Santos-Ocampo (25 July 1931 – 29 June 2012) made important contributions to treatments and policies that curbed debilitating and sometimes deadly diarrhoea-related diseases and malnutrition in children.
Singaporean physician Oon Chiew Seng (1916 – 31 March 2022) advanced dementia care and research in Singapore, and co-founded the Apex Harmony Lodge, the nation’s first nursing home for residents with dementia.
Vietnamese surgeon Tôn Thất Tùng (10 May 1912 – 7 May 1982) developed a pioneering technique that reduced the risks and mortality rate of liver operations.
Michiaki Takahashi (17 February 1928 – 16 December 2013) was a Japanese virologist who developed the first chickenpox vaccine.
Irene Ayako Uchida’s (8 April 1917 – 30 July 2013) strides to understand genetic diseases such as Down syndrome paved the way for early screening of chromosomal abnormalities in foetuses.
Baron Kitasato Shibasaburo (29 January 1856 – 13 June 1931) was a Japanese physician and bacteriologist whose work led to a new understanding of preventing and treating tetanus, diphtheria and anthrax.
Maggie Lim (5 January 1913 – November 1995) was a Singaporean physician who promoted family planning and expanded the access to clinics to improve the quality of life for mothers and children in Singapore’s early days.
By isolating soil microorganisms and studying the compounds they produce, Satoshi Omura (born 1935) discovered almost 500 organic compounds with unique properties that were produced by these microorganisms, including many new antibiotics.
The founder of the Adyar Cancer Institute in India, Muthulakshmi Reddy (30 July 1886 – 22 July 1968), fought to uplift women and girls from impoverished situations.
Chinese-American virologist and molecular biologist Flossie Wong-Staal (27 August 1946 – 8 July 2020) was the first scientist to clone HIV and determine the function of its genes.
Maharani Chakravorty (1937 – 2015) was one of India’s earliest molecular biologists whose research paved the way for advances in the treatment of bacterial and viral infections.
Archana Sharma (16 February 1932 - 14 January 2008) conducted research into plant and human genetics that expanded the understanding of both botany and human health. In relation to botany, she uncovered the means by which asexually-reproducing plants evolve into new species.
The first Thai woman to receive a degree in medicine, Margaret Lin Xavier (29 May 1898 – 6 December 1932), is best remembered for her compassion towards her less privileged patients.
Husband and wife team, Kimishige (3 December 1925 – 6 July 2018) and Teruko Ishizaka (28 September 1926 – 4 June 2019) discovered the antibody class Immunoglobulin E (IgE) that triggers allergic reactions. They also discovered that IgE antibodies attach to white blood cells, known as mast cells, releasing histamine, which causes allergic reactions.
Husband and wife team, Kimishige (3 December 1925 – 6 July 2018) and Teruko Ishizaka (28 September 1926 – 4 June 2019) discovered the antibody class Immunoglobulin E (IgE) that triggers allergic reactions. They also discovered that IgE antibodies attach to white blood cells, known as mast cells, releasing histamine, which causes allergic reactions.
In 1915, Koichi Ichikawa along with pathologist Katsusaburo Yamagiwa became the first to prove that chronic exposure to chemicals can cause cancer.
In 1915, pathologist Katsusaburo Yamagiwa and his research assistant Koichi Ichikawa became the first to prove that chronic exposure to chemicals can cause cancer.
Ogino Ginko (3 March 1851 – 23 June 1913) was the first registered female doctor to practise modern medicine in Japan.
Syed Qasim Mehdi (13 February 1941 – 28 September 2016) was a Pakistani molecular biologist who was a founding member of the Human Genome Diversity Project (HGDP), which assessed human diversity by studying human migration, mutation rates, relationships between different populations, genes involved in height and selective pressure.
Salimuzzaman Siddiqui (19 October 1897 – 14 April 1994) was an artist and chemist from Pakistan whose research focused on natural products from plants.
Umetaro Suzuki (7 April 1874 – 20 September 1943) was a Japanese scientist best remembered for his research on beriberi, a disease caused by vitamin B1 deficiency, characterized by limb stiffness, paralysis and pain.
Barry Paw (29 August 1962 – 28 December 2017) was a biologist and oncologist who discovered several novel genes and their functions in red blood cells.
Chika Kuroda (24 March 1884 – 8 November 1968) was a Japanese chemist whose research focussed on the structures of natural pigments.
Indian organic chemist Asima Chatterjee (1917 to 2006) studied the medicinal properties of plant products, especially compounds known as vinca alkaloids.
David T. Wong (born 1936) is a Hong Kong-born American neuroscientist who is best known for discovering the antidepressant drug fluoxetine, better known as Prozac.
Wu Lien-teh (10 March 1879 – 21 January 1960) was a Malaysian-born doctor who invented a mask that effectively suppressed disease transmission. Winning the prestigious Queen’s Scholarship enabled Wu to become the first Chinese student to study medicine at the University of Cambridge.
Minoru Shirota (April 23, 1899 – March 10, 1982) was a Japanese microbiologist who invented the popular fermented drink Yakult.
After witnessing death and suffering as a youth in his home village during World War II, Nguyễn Tài Thu (6 April 1931 – 14 February 2021) set his sights on alleviating pain by becoming a doctor. After studying Traditional Chinese Medicine in China in the 1950s, Thu returned to Vietnam to serve in military hospitals. Eventually, he became the country’s foremost practitioner of acupuncture, a technique he first learned by inserting needles into himself.
Fe Villanueva del Mundo (27 November 1911 – 6 August 2011) was a Filipina paediatrician who founded the Philippines’ first paediatric hospital.
Korean parasitologist Seung-Yull Cho (16 November 1943 – 27 January 2019) is remembered largely for his pioneering works to control infections caused by helminthic parasites and his contribution to journal publishing.
Filipino chemist and pharmacist Manuel A. Zamora (29 March 1870 – 9 July 1929) is best remembered for his discovery of the tiki-tiki formula to combat beriberi, a disease caused by Vitamin B1 deficiency.
Indian scientist and physician Upendranath Brahmachari (19 December 1873–6 February 1946) is best known for creating a drug called Urea Stibamine, used to safely and reliably treat visceral leishmaniasis (or Kala-azar), a severe infection caused by the Leishmania parasite.
Thai physician and conservationist Boonsong Lekagul (1907 – 1992) made major contributions to the preservation of his country’s wildlife.
The research of Filipino pharmaceutical chemist Luz Oliveros-Belardo (3 November 1906 – 12 December 1999) focussed on essential oils and other chemicals derived from native Philippine plants.
Ground-breaking cancer researcher Kamal Jayasing Ranadive (8 November 1917 – 11 April 2001) advanced the understanding of the causes of leukaemia, breast cancer and oesophageal cancer through the use of animal models. She was also among the first to recognise how susceptibility to cancer is linked to tumour-causing interactions between hormones and viruses.
Japanese chemist Takamine Jokichi (3 November 1854 – 22 July 1922) founded the Tokyo Artificial Fertilizer Company, where he isolated a starch-digesting enzyme (named takadiastase) from the fungus Aspergillus oryzae.
Tsai-Fan Yu (1911 – 2 March 2007) was a Chinese-American physician and researcher who was the first female full professor at Mount Sinai School of Medicine. She discovered that gout, a condition characterized by the painful inflammation of joints, was caused by elevated levels of uric acid in the bloodstream.
A Japanese surgeon, Tetsuzo Akutsu (20 August 1922 – 9 August 2007) built the first artificial heart capable of keeping an animal alive.
Min Chueh Chang (10 October 1908 – 5 June 1991) was a Chinese-American biologist who studied fertilization in mammalian reproduction.
Esther Park (1877-1910), born Kim Jeom-dong, was the first female Korean physician to practise modern medicine in Korea and trained the first generation of Korean female doctors.